Physicians who have successfully entered the NP collaboration market often ask the same follow-up question: does the PA market work the same way? The truthful answer is: mostly yes, but with specific regulatory and structural differences that are significant enough to warrant understanding before entering a PA oversight arrangement. The income mechanics are similar — monthly retainer, asynchronous chart review, no per-encounter liability — but the regulatory framework governing physician-PA relationships was built on a different conceptual foundation than the one governing physician-NP relationships, and those differences create practical distinctions in agreement structure, controlled substance handling, state requirements, and rate-setting.
This guide explains the key differences between a physician assistant collaborative agreement and an NP collaboration arrangement — so physicians can assess both markets accurately, understand what each requires, and make deliberate decisions about whether to build a PA arrangement, an NP arrangement, or a combined portfolio that includes both.
According to the U.S. Bureau of Labor Statistics Occupational Outlook for Physician Assistants, the PA profession is projected to grow 28% over the next decade — faster than average for all occupations — adding tens of thousands of new PA practitioners who will need physician oversight in the states that require it. Combined with the NP workforce growth already transforming the collaboration market, this means the total addressable market for physician oversight is expanding on two fronts simultaneously.
The Regulatory Foundation: Why “Supervision” and “Collaboration” Are Not the Same Thing
The most important conceptual difference between PA and NP oversight arrangements is the regulatory model that defines the physician’s role. NP oversight arrangements are typically governed by a “collaborative practice” framework — the physician and NP work as clinical partners, with the physician providing oversight and consultation for specific activities as defined in the Collaborative Practice Agreement and state statute. PA oversight arrangements have historically been governed by a “supervision” or “delegation” framework — the physician is understood as the responsible supervisor who delegates specific clinical activities to the PA under defined conditions.
This is not merely semantic. The supervision model used in PA oversight historically implied a closer, more direct physician involvement than NP collaboration — and some state PA practice acts still use language that reflects stronger physician authority over PA practice than equivalent NP acts. In practice, many PA oversight arrangements look operationally similar to NP collaboration arrangements — asynchronous chart review, defined scope, monthly retainer — but the language in state statutes, agreement templates, and licensing board expectations can differ significantly enough to warrant separate due diligence.
Side-by-Side ComparisonPA vs. NP Collaboration: Every Dimension That Differs
| Dimension | 🩺 Physician Assistant (PA) Agreement | ⚕ Nurse Practitioner (NP) Agreement |
|---|---|---|
| Regulatory Model Label | Supervision / Delegation Physician “supervises” PA; PA practices “under supervision of” physician; delegation of specific clinical tasks is the operative concept |
Collaboration / Partnership Physician “collaborates with” NP; NP maintains clinical autonomy with physician serving as oversight partner; both parties sign Collaborative Practice Agreement |
| Governing Document Name | Supervision Agreement, Delegation Agreement, Collaborative Practice Agreement (varies significantly by state — terminology is not standardized) | Collaborative Practice Agreement (CPA), Protocol, Standardized Procedures Document, or Collaborative Agreement (varies by state but “collaborative” is the common thread) |
| Physician Title in Arrangement | Supervising Physician, Collaborating Physician, Delegating Physician (state-dependent; “supervising physician” is most common) | Collaborating Physician, Supervisory Physician (in some states), Oversight Physician (informal); “collaborating” is most common nationally |
| Implied Physician Authority Level | Higher Implied — PA supervision model historically implies stronger physician oversight authority; physician responsibility framing is more pronounced in state statutes | Moderate — NP collaboration model frames physician as partner/consultant rather than supervisor; physician authority is more bounded to agreement scope |
| Workforce Size (National) | ~170,000 certified PAs in the US as of 2025 (NCCPA data) | Larger Market — ~400,000+ NPs as of 2025; approximately 2.5× the PA workforce; creates proportionally larger collaboration market |
| Monthly Physician Rate Range | $1,000–$3,200/month (specialty and state dependent; typically slightly below NP market due to smaller practice volume) | Higher Ceiling — $1,200–$5,000/month; psychiatry and dermatology specialties command premium rates unavailable in PA market |
| Controlled Substance Prescribing | PA CS prescribing authority varies by state; many states require physician co-signature or specific delegation for CS prescribing; DEA registration is typically independent but supervision relationship must be documented | NP CS prescribing authority varies by state and NP specialty; in collaboration states, CS prescribing oversight is a standard agreement scope item; physician CS premium applies in both markets |
| States Requiring Physician Oversight | Most states retain some form of required physician involvement for PA practice, though the specific requirement varies widely; fewer states have moved to PA full practice authority than NP FPA | Approximately 26 states retain required physician collaboration for NP practice; the remaining states have full NP practice authority; NP FPA movement is further advanced than PA FPA movement |
| Independent Practice Movement | PA profession has been slower to move toward independent practice authority; most states still require physician involvement in some form | More Mature Movement — NP full practice authority has been adopted by more states; the NP independence legislative movement is further advanced, creating some long-term demand risk for collaboration income in FPA states |
| Remote / Telehealth Market Size | Smaller telehealth PA practice market; PA telehealth practices exist but in lower volume than NP equivalent; collaboration income from PA market is additive, not primary | Much Larger — NP telehealth market is substantially larger; hundreds of telehealth NP practice segments including weight loss, behavioral health, and women’s health; primary collaboration income market |
| Agreement Exclusivity Provisions | PA supervision agreements vary; some require the supervising physician to be the PA’s “primary” supervisor; check for language limiting simultaneous arrangements | NP collaboration agreements typically have no exclusivity restriction; physicians commonly hold 2–4 simultaneous arrangements |
| Best Use in Portfolio | Secondary income channel — adds to NP collaboration income base without replacing it; particularly valuable in states where both NP and PA require oversight | Primary income channel — higher market volume, higher rate ceiling, stronger exclusivity absence; the foundation of most physician collaboration income portfolios |
What is the fundamental regulatory difference between PA and NP oversight requirements — and why does it matter practically for physicians?
The fundamental difference is conceptual: PA practice in most states is grounded in a physician delegation model, where the PA is authorized to perform specific clinical activities that the supervising physician has delegated; NP practice in collaboration states is grounded in a collaborative partnership model, where the NP practices within their scope and the physician provides oversight and consultation as defined in the agreement. In practice, this conceptual difference creates several operational distinctions. First, PA oversight agreements in some states use more prescriptive language about what the physician must actively oversee — whereas NP collaboration agreements tend to define oversight in percentage-based chart review terms. Second, PA supervising physicians in some states face more specific review requirements including on-site availability provisions that are less common in NP collaboration agreements. Third, the controlled substance prescribing chain for PAs is sometimes more directly connected to the supervising physician’s DEA registration in ways that NP CS prescribing is not — though this varies significantly by state. For the physician evaluating their first PA oversight arrangement, the practical implication is: read the agreement language carefully against your specific state’s PA practice act, not just against what you know from NP collaboration. The supervising physician requirements in Tennessee, for example, differ between the state’s PA practice act and the NP practice act — and a physician using the NP agreement as the template for a PA oversight arrangement may be missing PA-specific provisions that the state’s medical board will expect to find.
PA Practice Types Seeking Physician Oversight: The Market Segments Available
The PA oversight market is smaller than the NP market in absolute volume but meaningful as an income supplement — particularly for physicians who already hold state licenses for required-collaboration markets and are looking to maximize the income per state license they hold. The practice types seeking PA physician oversight span the same clinical settings as NP practices, with some concentration differences.
| PA Practice Type | Market Demand | Physician Income Range | Clinical Oversight Complexity | Best Fit Physician Specialty |
|---|---|---|---|---|
| Surgical / Procedural PA Practices | ↑ High | $1,500–$3,200/mo | Moderate-high — procedural scope oversight; physician should have comfort with relevant surgical specialty | Surgery, Orthopedics, ENT, Urology; specialty match preferred |
| Emergency Medicine PA Practices | ↑ Active | $1,200–$2,800/mo | High — acute care complexity, CS prescribing common, broader scope than primary care | Emergency Medicine, IM, FM with acute care experience |
| Primary Care PA Practices (Telehealth) | → Growing | $1,000–$2,200/mo | Low-moderate — similar to NP primary care oversight in operational terms; standard chart review | FM, IM; any physician with primary care background |
| Dermatology PA Practices | ↑ High | $1,500–$3,000/mo | Moderate — dermatology scope; specialty scarcity premium applies even for PA oversight | Dermatology preferred; FM with dermatology interest may qualify in some states |
| Orthopedics / Sports Medicine PA | → Moderate-Active | $1,000–$2,500/mo | Moderate — musculoskeletal scope; CS prescribing for acute pain common | Orthopedics, Sports Medicine, FM with MSK background |
| Weight Loss / Metabolic PA Practices | ↑ Growing | $1,200–$2,500/mo | Low-moderate — similar to weight loss NP oversight; GLP-1 protocol review; no specialty certification required | FM, IM, Obesity Medicine; any physician comfortable with GLP-1 pharmacology |
PA Oversight Requirements by State: Where Your License Creates PA Income
The PA oversight market is geographically distinct from the NP market in some important ways. While the NP collaboration market is most concentrated in Deep South required-collaboration states (Texas, South Carolina, Alabama, Florida), the PA oversight market is more evenly distributed because more states retain some physician oversight requirement for PA practice — including some states that have already granted NPs full practice authority.
| State | PA Oversight Requirement | NP Status (for comparison) | PA Monthly Rate | Market Notes |
|---|---|---|---|---|
| Texas | Required Supervision | Required Collaboration | $1,200–$2,800 | Both PA and NP markets require physician oversight; TX physicians can hold both PA and NP arrangements simultaneously — the highest combined market in the country |
| Florida | Required Supervision | Required Protocol | $1,100–$2,600 | FL PA supervision agreements required; physician demand for both PA and NP oversight is among the highest nationally by volume |
| Georgia | Required Supervision | Required Protocol | $1,000–$2,400 | GA requires physician supervision for both PA and NP practice; combined market creates strong income opportunity for GA-licensed physicians |
| Tennessee | Required Supervision | Required CPA | $1,000–$2,400 | TN maintains supervision requirements for PAs; physician oversight income available from both PA and NP arrangements with a single TN license |
| Missouri | Collaborative Required | Reduced Practice | $900–$2,200 | The missouri collaborative practice agreement framework applies to both NP and PA oversight; MO physicians can hold both arrangement types |
| Indiana | Collaboration Required | Transitioning | $900–$2,000 | The indiana collaborative practice agreement landscape includes PA oversight requirements; IN-licensed physicians have a dual market opportunity |
| Michigan | Collaboration Required | Reduced Practice | $900–$2,000 | Michigan michigan nurse practitioner collaborative agreement requirements coexist with PA oversight requirements; both markets active in MI |
| New York | Supervision Required for PA | Full Practice Authority | $900–$2,200 | NY granted NP full practice authority but maintains PA supervision requirements — creating a PA-specific physician oversight market that does not exist for NPs; unique dual-status state |
| California | Collaboration Required for PA | Full Practice Authority | $800–$2,000 | Like NY, CA granted NP FPA but maintains collaborative agreement requirements for PAs; collaborating physician california market has PA-specific oversight demand even in an FPA-NP state |
| Colorado | Collaboration Required for PA | Full Practice Authority | $800–$1,800 | CO NPs practice independently but PAs retain collaboration requirements; understanding physician collaborations for nps and pas in Colorado shows this important dual-status nuance |
| New York (NP FPA / PA Required) | PA Supervision Required | NP — Full Practice Authority | $1,000–$2,200 | Collaborating physicians in new york who want NP arrangement income must enter the voluntary NP market — but PA supervision income is structurally required, creating a distinct mandatory PA market in NY |
Both California and New York have granted NP full practice authority while maintaining physician oversight requirements for PAs. This creates a counterintuitive market: physicians with CA or NY licenses cannot generate structurally required income from NP oversight — but they can generate structurally required income from PA oversight. For physicians currently licensed only in FPA-NP states, the PA oversight market may be the only mandatory-demand physician income channel available without obtaining new state licenses. This is worth knowing before concluding that FPA state licenses cannot generate collaboration income.
“California and New York granted NPs full practice authority — and simultaneously retained physician oversight requirements for PAs. A physician in either state who only pursues NP collaboration is leaving a structurally required income market entirely uncaptured, simply because they did not check whether their state’s PA practice act differs from its NP practice act.”
How does physician income from PA arrangements compare to NP arrangements — and should physicians pursue both?
The income comparison between PA vs NP collaboration agreements consistently shows the NP market generating higher per-arrangement income in most states — for two structural reasons: the NP workforce is approximately 2.5 times larger than the PA workforce, creating more market volume, and the NP collaboration market has developed a more mature premium pricing structure for specialty physicians (particularly psychiatrists and dermatologists) that the PA market has not yet replicated to the same degree. A psychiatrist can earn $2,500 to $5,000 per month from an NP psychiatric practice oversight arrangement in South Carolina; the equivalent PA psychiatric practice oversight arrangement would typically pay $1,500 to $2,800 per month in the same state. However, the comparison changes significantly in FPA-NP states where PA oversight is still required — in California, New York, and Colorado, the PA market is the only structurally mandatory physician oversight income channel available for physicians who do not want to pursue voluntary NP arrangements at the lower FPA-market rates. For physicians in required-collaboration states for both NP and PA practice — Texas, Florida, Georgia, Tennessee, and others — the optimal strategy is to pursue both arrangement types. A Texas physician holding two NP collaboration arrangements at $1,800/month each plus one PA supervision arrangement at $1,400/month earns $72,000 annually from three separate oversight arrangements — with the PA arrangement adding meaningful income on top of the NP base without conflicting with any exclusivity provisions, which are absent from properly structured collaboration agreements.
How PA and NP Agreement Structures Actually Differ: A Document-Level Comparison
When physicians evaluate specific PA vs NP oversight arrangements, the differences that matter most in practice are in the agreement documents themselves. The table below maps the key agreement provisions where PA and NP documents structurally differ — so physicians know what to look for and what to negotiate in each context.
| Agreement Provision | 🩺 PA Supervision Agreement | ⚕ NP Collaborative Practice Agreement |
|---|---|---|
| Physician Authority Language | “Supervises” PA; physician is the delegating authority; PA acts “under supervision of” physician; supervision relationship must be specified | “Collaborates with” NP; physician is an oversight partner, not a superior; NP retains clinical autonomy within defined scope |
| Physician Availability Requirement | May specify on-site or same-location availability requirements in some states; some PA acts require physician to be reachable within defined distances or time windows during PA work hours | Typically requires consultation availability by phone or secure message during defined hours; physical proximity or location requirements are rare in modern NP CPA statutes |
| Controlled Substance Prescribing Scope | PA CS prescribing authority is tied to supervising physician’s delegation; some states require physician co-signature for specific CS drug classes or schedules; physician DEA relationship may be more direct | NP CS prescribing authority in collaboration states typically defined by state pharmacy board and NP prescriptive authority law; physician oversight of CS prescribing is agreement-defined but not co-signature-based in most states |
| Scope of Practice Definition | Scope is defined by what the physician delegates; PA can practice within the physician’s delegated scope; scope limitations may be set more specifically by the supervising physician’s specialty | Scope is defined by NP specialty certification and state statute; physician does not “set” the NP’s scope — they agree to provide oversight for the NP’s statutorily defined scope |
| Chart Review Requirements | State PA acts vary widely on chart review percentage requirements; some specify 10% of charts, others leave it to agreement terms; consistency with NP review requirements is not guaranteed | Typically 10–20% of charts as specified in state NP practice statute; more standardized nationally because NP collaboration law has been more specifically codified in most states |
| Agreement Filing / Registration | Some states require PA supervision agreements to be filed with or approved by the state medical board; physician must verify state-specific filing requirements before beginning PA oversight | Most state NP CPA requirements involve maintaining the agreement in the practice records rather than filing with a board; some states require registration but filing is less universally required than in PA oversight |
| Number of Concurrent Arrangements | Some states limit the number of PAs a physician can supervise simultaneously; verify state-specific caps before accepting multiple PA arrangements | Most states do not limit NP collaboration numbers for a single physician; some states have specific caps (Pennsylvania limits PA collaboration numbers) but most do not |
| Termination Notice | Varies; some state PA acts require 30-day minimum notice of supervision termination with notification to the state board; verify state requirements | Typically 30–60 days per agreement terms; less frequently requires board notification but verify state-specific requirements |
Before signing any PA supervision agreement, verify three things specific to PA oversight that NP collaboration does not require: (1) Does your state require physician-PA supervision agreements to be filed with or approved by the state medical board? If yes, both parties must complete this before the PA can legally practice under your oversight. (2) Does your state limit the number of PAs a physician can simultaneously supervise? Some states have caps that do not exist for NP collaboration. (3) Does your state’s PA practice act require any specific on-site availability provision — meaning the physician must be reachable within a defined proximity or time window during PA working hours? If yes, negotiate this explicitly in the agreement to ensure it matches your actual availability model.
Why the Most Effective Physician Collaboration Income Strategy Includes Both Markets
The physicians who generate the highest total oversight income from their medical licenses are not those who chose the NP market or the PA market. They are those who recognized that in many required-collaboration states, a single physician license creates parallel income opportunities in both markets simultaneously — and that the combined NP + PA portfolio compounds income in ways that neither market alone can match.
A Texas-licensed physician can hold two NP collaboration arrangements generating $1,800 per month each ($43,200 annually) while simultaneously holding one PA supervision arrangement generating $1,500 per month ($18,000 annually) — for a combined $61,200 annually from three separate oversight relationships, each with no exclusivity restriction and each generating independent monthly retainer income. The total time commitment across the three arrangements is 10 to 15 hours per week of asynchronous chart review — a meaningful commitment, but one that generates an effective hourly rate of $85 to $120 across the portfolio.
Can a physician simultaneously hold both NP collaboration and PA supervision arrangements — and do they interfere with each other legally or practically?
Yes, a physician can simultaneously hold both NP collaboration and PA supervision arrangements, and in properly structured agreements they do not legally or practically interfere with each other. The two arrangement types are governed by separate state statutes — the PA practice act and the NP practice act in each state — and compliance with one does not affect compliance with the other. The only interference risk is an exclusivity or non-compete clause in one agreement that is broad enough to reach across to the other market — which is why every agreement must be reviewed for scope. An NP collaboration agreement that contains language restricting the physician from “supervising any other healthcare provider” practicing in the same specialty or geographic area could inadvertently restrict PA arrangements if not carefully scoped — though this is uncommon in well-drafted agreements. Practically, the time commitment of multiple simultaneous arrangements requires active management: a physician with two NP collaboration arrangements and one PA supervision arrangement needs approximately 12 to 16 hours per week of asynchronous chart review time, and should maintain a session log to ensure they are satisfying the review percentage required by each state’s specific requirements. The strongest income portfolio combines the high-volume, high-rate NP market with the PA market as an income amplifier — particularly in states like California and New York where the PA market is structurally mandatory while the NP market is voluntary, and in states like Texas and Tennessee where both markets are structurally required, creating the broadest income base from a single state license.
The key insight for every physician evaluating the collaboration income market: The NP and PA markets are not alternatives — they are additive. A physician who only pursues NP collaboration is leaving PA oversight income uncaptured in every state where their license creates PA oversight demand. A physician who only evaluates PA collaboration is overlooking a market that is 2.5× larger by workforce volume and commands significantly higher per-arrangement rates in specialty markets. The complete physician oversight income portfolio includes both, sequenced by which market creates immediate income in the states where the physician currently holds licenses, and expanded using IMLC licensing into the states where both markets create the highest combined income.
Access Both the NP and PA Collaboration Markets — From One Platform
CollaboratingPhysician.com connects licensed physicians with NP and PA practices by specialty and state — so you can build a complete oversight income portfolio from both markets simultaneously.
Find NP and PA Arrangements in Your State →Two Markets, One License: What to Do With This Information
The physician assistant collaborative agreement and the NP collaborative practice agreement are different documents, governed by different regulatory frameworks, with different historical conceptual models — but they create the same fundamental physician income mechanism: a monthly retainer for defined, asynchronous chart review and consultation availability in states that require physician oversight for advanced practice provider practice.
Understanding how PA collaboration differs from NP arrangements — in regulatory model, agreement language, controlled substance handling, state-specific requirements, and income structure — allows physicians to approach both markets with the specific knowledge each requires, rather than assuming they are identical or assuming the one they entered first fully represents the other.
The most important practical conclusion: check whether your state’s PA practice act requires physician oversight, even if the NP practice act has already granted NPs full independence. California and New York are the most prominent examples of states where this asymmetry creates a PA-specific income market that many physicians do not know exists. And in states where both markets require physician oversight, the combined NP + PA arrangement portfolio is the highest-income, most efficient use of a single state medical license in the physician collaboration income model.
PA and NP practice authority requirements vary significantly by state and are subject to legislative change. Always verify current requirements with your state’s medical board, PA board, and nursing board before entering any oversight arrangement. External workforce data referenced from the U.S. Bureau of Labor Statistics Occupational Outlook Handbook (bls.gov). Income ranges reflect 2025–2026 market estimates; individual results vary. This guide is for informational purposes only and does not constitute legal or financial advice.
